Travere Therapeutics, Inc. <TVTX.O>: Wells Fargo Raises Target Price to $80 From $65
TVTX•Related News
Hyliion wins USD 41.7 million U.S. Navy contract for multi-megawatt KARNO power modules
HYLN•
Madrigal Pharmaceuticals to present at Canaccord Genuity Annual Growth Conference
MDGL•
Guerrilla RF Q2 revenue rises 49% to record high
GUER•
Pacira publishes positive two-year Phase 1 data for PCRX-201 gene therapy in knee osteoarthritis
PCRX•
Shift4 slides after cutting annual revenue forecast
FOUR•